Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva's Double-Edged Sword
Motley Fool
Wednesday, May 5, 2010 - 9:20pm
tags:
Teva Pharmaceuticals, MS, Copaxone, generics, Mirapex, Boehringer Ingelheim, Ratiopharm
Merck: Jury rules against plaintiff over Fosamax
Yahoo/AP
Wednesday, May 5, 2010 - 9:14pm
tags:
Merck, Fosamax, osteoporosis
When the FDA Ignores Its Advisors
Forbes
Wednesday, May 5, 2010 - 9:09pm
tags:
FDA, pirfenidone, InterMune, advisory panels
Generics industry loses top lobbyist Jaeger
Fierce Pharma
Wednesday, May 5, 2010 - 4:06pm
tags:
generics, lobbying, Kathleen Jaeger
Why the Bristol-Myers Share Repurchase Plan Gets a Thumbs Down
Seeking Alpha
Wednesday, May 5, 2010 - 4:04pm
tags:
Bristol-Myers Squibb, share repurchase
Why Biotechs Should Take A Page From Medical-Device Playbook
WSJ Online
Wednesday, May 5, 2010 - 11:22am
tags:
medical devices, biotech, venture capital
What Intermune's Smackdown Tells Us About the FDA
Forbes
Wednesday, May 5, 2010 - 11:18am
tags:
FDA, InterMune, pirfenidone
ZymoGenetics: Warming Up or Cooling Off?
Motley Fool
Wednesday, May 5, 2010 - 11:17am
tags:
ZymoGenetics
Micromet 1Q loss widens on costs
Yahoo/AP
Wednesday, May 5, 2010 - 11:16am
tags:
earnings, Micromet
KV Pharmaceutical gets positive manufacturing review
Reuters
Wednesday, May 5, 2010 - 11:07am
tags:
KV Pharmaceutical, FDA, drug manufacturing
The InterMune Debacle Post-Script
TheStreet.com
Wednesday, May 5, 2010 - 11:06am
tags:
pirfenidone, InterMune, FDA, Pozen, Gilead Sciences
E&Y: 2009 forever changed the biopharma industry
Fierce Biotech
Wednesday, May 5, 2010 - 11:04am
tags:
Earnst and Young, pharma industry, biotech
Pharmacyclics halves Q3 loss to $3.1M
Bizjournals.com
Wednesday, May 5, 2010 - 11:02am
tags:
earnings, Pharmacyclics
Steve Nissen vs. GlaxoSmithKline
In the Pipeline
Wednesday, May 5, 2010 - 10:31am
tags:
GSK, Steve Nissen
Pfizer and Merck Earnings Impress Investors
Daily Finance
Wednesday, May 5, 2010 - 9:56am
tags:
Pfizer, Merck, earnings
Live from BIO: What do biotech VCs want?
Fierce Biotech
Wednesday, May 5, 2010 - 9:54am
tags:
BIO, biotech, venture capital
J&J Sales Reps Must Ride With Compliance Police
Pharmalot
Wednesday, May 5, 2010 - 9:49am
tags:
JNJ, sales reps, compliance, off-label, Topamax
Alexza files for up to $75M stock sale
Bizjournals.com
Wednesday, May 5, 2010 - 9:44am
tags:
stock offering, Alexza
Cephalon Beats; Updates Guidance
Yahoo/Zacks.com
Wednesday, May 5, 2010 - 9:43am
tags:
Cephalon, guidance, earnings
King Pharma swings to a profit, revenue falls
Marketwatch
Wednesday, May 5, 2010 - 9:42am
tags:
King, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.